Login
Evidence Feed
About
Diagnostics
New
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
GENE:
IDH1 (Isocitrate dehydrogenase (NADP(+)) 1)
i
Other names:
HEL-216, HEL-S-26, Epididymis Luminal Protein 216, Isocitrate Dehydrogenase 1 (NADP+), Epididymis Secretory Protein Li 26, IDH1, Isocitrate Dehydrogenase (NADP(+)) 1, Isocitrate Dehydrogenase 1 (NADP+), Soluble
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Entrez ID:
3417
Related tests:
‹
Guardant360® CDx (54)
MSK-IMPACT (21)
Oncomine™ Dx Target Test (11)
FoundationOne® Heme CDx (10)
TruSeq®Amplicon - Cancer Panel (5)
Oncomine™ Pan-Cancer Cell-Free Assay (4)
Abbott RealTime IDH1 (3)
Guardant360 TissueNext™ (2)
UW-Oncoplex™ (2)
Archer® FusionPlex® Comprehensive Thyroid & Lung (CTL) Kit (1)
AML Express™
AVENIO Tumor Tissue CGP Kit
AVENIO Tumor Tissue Expanded Kit
AVENIO ctDNA Expanded Kit
Altera
AmoyDx® HANDLE Classic NGS Panel
AnchorAIM® 72 gene detection for individualized treatment of solid tumors
Archer® FusionPlex® Acute Lymphoblastic Leukemia (ALL)
Archer® FusionPlex® Myeloid Kit
Archer® VariantPlex® Comprehensive Thyroid and Lung (CTL) kit
Archer® VariantPlex® Myeloid panel
Archer® VariantPlex® Solid Tumor Kit
Archer™ FusionPlex™ Core Solid Tumor Panel
Archer™ VARIANTPlex™ Complete Solid Tumor panel
Archer™ VARIANTPlex™ Pan Solid Tumor panel
Find It®
Follow It®
FusionPlex™ Pan-Heme panel
IDH1 R132H (MRQ-67) Rabbit Monoclonal Primary Antibody
Idylla™ IDH1-2 Mutation Assay
InVisionSeq™
Labcorp® Plasma Complete™
LiquidHALLMARK®
LiquidPlex™
Myeloid Molecular Profile
NGS Targeted Hotspot Panel
NeoLAB® Solid Tumor Liquid Biopsy
Northstar Select™
OncoGuide™ NCC Oncopanel System
OncoKey™ SL 525 Plus Assay
OncoKey™ SL 60 Plus Assay
OncoPanel™ Assay
OncoSTRAT&GO
OncoScan™ CNV Plus Assay
Oncomine Focus Assay
Oncomine Myeloid Assay GX
Oncomine Precision Assay
Oncomine Tumor Mutation Load Assay
Oncomine™ Myeloid MRD Assays
OptiSeq™ Lung Cancer Panel
OptiSeq™ Pan-Cancer Gene Panel
SOPHiA DDM™ Myeloid Solution
SOPHiA DDM™ Solid Tumor Plus Solution
SOPHiA Myeloid Plus Solution
SafeSEQ AML MRD Assay
StrataNGS™ Test
SureSeq™ Myeloid MRD Panel
SureSeq™ Pan-Myeloid Panel
Tempus xF Assay
Tempus xF+ Panel
TruSight Myeloid Sequencing Panel
TruSight Oncology Comprehensive
TruSight Tumor 170 Assay
VarMap™ Pan-Cancer NGS Panel
Vartrace® AML Panel
oncoReveal™ Core LBx
oncoReveal™ Multi-Cancer with CNV & RNA Fusion Panel
oncoReveal™ Solid Tumor v2 Panel
Guardant360® CDx (54)
MSK-IMPACT (21)
Oncomine™ Dx Target Test (11)
FoundationOne® Heme CDx (10)
TruSeq®Amplicon - Cancer Panel (5)
Oncomine™ Pan-Cancer Cell-Free Assay (4)
Abbott RealTime IDH1 (3)
Guardant360 TissueNext™ (2)
UW-Oncoplex™ (2)
Archer® FusionPlex® Comprehensive Thyroid & Lung (CTL) Kit (1)
AML Express™
AVENIO Tumor Tissue CGP Kit
AVENIO Tumor Tissue Expanded Kit
AVENIO ctDNA Expanded Kit
Altera
AmoyDx® HANDLE Classic NGS Panel
AnchorAIM® 72 gene detection for individualized treatment of solid tumors
Archer® FusionPlex® Acute Lymphoblastic Leukemia (ALL)
Archer® FusionPlex® Myeloid Kit
Archer® VariantPlex® Comprehensive Thyroid and Lung (CTL) kit
Archer® VariantPlex® Myeloid panel
Archer® VariantPlex® Solid Tumor Kit
Archer™ FusionPlex™ Core Solid Tumor Panel
Archer™ VARIANTPlex™ Complete Solid Tumor panel
Archer™ VARIANTPlex™ Pan Solid Tumor panel
Find It®
Follow It®
FusionPlex™ Pan-Heme panel
IDH1 R132H (MRQ-67) Rabbit Monoclonal Primary Antibody
Idylla™ IDH1-2 Mutation Assay
InVisionSeq™
Labcorp® Plasma Complete™
LiquidHALLMARK®
LiquidPlex™
Myeloid Molecular Profile
NGS Targeted Hotspot Panel
NeoLAB® Solid Tumor Liquid Biopsy
Northstar Select™
OncoGuide™ NCC Oncopanel System
OncoKey™ SL 525 Plus Assay
OncoKey™ SL 60 Plus Assay
OncoPanel™ Assay
OncoSTRAT&GO
OncoScan™ CNV Plus Assay
Oncomine Focus Assay
Oncomine Myeloid Assay GX
Oncomine Precision Assay
Oncomine Tumor Mutation Load Assay
Oncomine™ Myeloid MRD Assays
OptiSeq™ Lung Cancer Panel
OptiSeq™ Pan-Cancer Gene Panel
SOPHiA DDM™ Myeloid Solution
SOPHiA DDM™ Solid Tumor Plus Solution
SOPHiA Myeloid Plus Solution
SafeSEQ AML MRD Assay
StrataNGS™ Test
SureSeq™ Myeloid MRD Panel
SureSeq™ Pan-Myeloid Panel
Tempus xF Assay
Tempus xF+ Panel
TruSight Myeloid Sequencing Panel
TruSight Oncology Comprehensive
TruSight Tumor 170 Assay
VarMap™ Pan-Cancer NGS Panel
Vartrace® AML Panel
oncoReveal™ Core LBx
oncoReveal™ Multi-Cancer with CNV & RNA Fusion Panel
oncoReveal™ Solid Tumor v2 Panel
›
Associations
(160)
News
Trials
VERI cancer hierarchy
Reset Filters
IDH1 mutation
Cholangiocarcinoma
IDH1 mutation
Cholangiocarcinoma
ivosidenib
Sensitive: A1 - Approval
ivosidenib
Sensitive
:
A1
ivosidenib
Sensitive: A1 - Approval
ivosidenib
Sensitive
:
A1
IDH1 mutation
Acute Myelogenous Leukemia
IDH1 mutation
Acute Myelogenous Leukemia
olutasidenib
Sensitive: A1 - Approval
olutasidenib
Sensitive
:
A1
olutasidenib
Sensitive: A1 - Approval
olutasidenib
Sensitive
:
A1
IDH1 mutation
Acute Myelogenous Leukemia
IDH1 mutation
Acute Myelogenous Leukemia
ivosidenib
Sensitive: A1 - Approval
ivosidenib
Sensitive
:
A1
ivosidenib
Sensitive: A1 - Approval
ivosidenib
Sensitive
:
A1
IDH1 R132
Acute Myelogenous Leukemia
IDH1 R132
Acute Myelogenous Leukemia
ivosidenib
Sensitive: A1 - Approval
ivosidenib
Sensitive
:
A1
ivosidenib
Sensitive: A1 - Approval
ivosidenib
Sensitive
:
A1
IDH1 mutation
Myelodysplastic Syndrome
IDH1 mutation
Myelodysplastic Syndrome
ivosidenib
Sensitive: A1 - Approval
ivosidenib
Sensitive
:
A1
ivosidenib
Sensitive: A1 - Approval
ivosidenib
Sensitive
:
A1
IDH1 R132
Cholangiocarcinoma
IDH1 R132
Cholangiocarcinoma
ivosidenib
Sensitive: A1 - Approval
ivosidenib
Sensitive
:
A1
ivosidenib
Sensitive: A1 - Approval
ivosidenib
Sensitive
:
A1
IDH1 mutation
Astrocytoma
IDH1 mutation
Astrocytoma
vorasidenib
Sensitive: A1 - Approval
vorasidenib
Sensitive
:
A1
vorasidenib
Sensitive: A1 - Approval
vorasidenib
Sensitive
:
A1
IDH1 mutation
Oligodendroglioma
IDH1 mutation
Oligodendroglioma
vorasidenib
Sensitive: A1 - Approval
vorasidenib
Sensitive
:
A1
vorasidenib
Sensitive: A1 - Approval
vorasidenib
Sensitive
:
A1
IDH1 mutation
Astrocytoma
IDH1 mutation
Astrocytoma
temozolomide
Sensitive: A2 - Guideline
temozolomide
Sensitive
:
A2
temozolomide
Sensitive: A2 - Guideline
temozolomide
Sensitive
:
A2
IDH1 mutation
Acute Myelogenous Leukemia
IDH1 mutation
Acute Myelogenous Leukemia
venetoclax
Sensitive: A2 - Guideline
venetoclax
Sensitive
:
A2
venetoclax
Sensitive: A2 - Guideline
venetoclax
Sensitive
:
A2
IDH1 mutation
Sarcoma
IDH1 mutation
Sarcoma
ivosidenib
Sensitive: A2 - Guideline
ivosidenib
Sensitive
:
A2
ivosidenib
Sensitive: A2 - Guideline
ivosidenib
Sensitive
:
A2
IDH1 mutation + Chr del(1p) + Chr del(19q)
Oligodendroglioma
IDH1 mutation + Chr del(1p) + Chr del(19q)
Oligodendroglioma
temozolomide
Sensitive: A2 - Guideline
temozolomide
Sensitive
:
A2
temozolomide
Sensitive: A2 - Guideline
temozolomide
Sensitive
:
A2
^
^
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.